These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. Terrinoni A; Smith FJ; Didona B; Canzona F; Paradisi M; Huber M; Hohl D; David A; Verloes A; Leigh IM; Munro CS; Melino G; McLean WH J Invest Dermatol; 2001 Dec; 117(6):1391-6. PubMed ID: 11886499 [TBL] [Abstract][Full Text] [Related]
11. Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. Zhao Y; Gartner U; Smith FJ; McLean WH J Invest Dermatol; 2011 May; 131(5):1045-52. PubMed ID: 21390048 [TBL] [Abstract][Full Text] [Related]
12. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Smith FJ; Jonkman MF; van Goor H; Coleman CM; Covello SP; Uitto J; McLean WH Hum Mol Genet; 1998 Jul; 7(7):1143-8. PubMed ID: 9618173 [TBL] [Abstract][Full Text] [Related]
13. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Bowden PE; Haley JL; Kansky A; Rothnagel JA; Jones DO; Turner RJ Nat Genet; 1995 Jul; 10(3):363-5. PubMed ID: 7545493 [TBL] [Abstract][Full Text] [Related]
14. The molecular genetics of keratin disorders. Smith F Am J Clin Dermatol; 2003; 4(5):347-64. PubMed ID: 12688839 [TBL] [Abstract][Full Text] [Related]
15. The phenotypic and molecular genetic features of pachyonychia congenita. McLean WH; Hansen CD; Eliason MJ; Smith FJ J Invest Dermatol; 2011 May; 131(5):1015-7. PubMed ID: 21430705 [TBL] [Abstract][Full Text] [Related]
17. A mutation detection strategy for the human keratin 6A gene and novel missense mutations in two cases of pachyonychia congenita type 1. Smith FJ; McKenna KE; Irvine AD; Bingham EA; Coleman CM; Uitto J; McLean WH Exp Dermatol; 1999 Apr; 8(2):109-14. PubMed ID: 10232400 [TBL] [Abstract][Full Text] [Related]
18. Development of quantitative molecular clinical end points for siRNA clinical trials. Hickerson RP; Leachman SA; Pho LN; Gonzalez-Gonzalez E; Smith FJ; McLean WH; Contag CH; Leake D; Milstone LM; Kaspar RL J Invest Dermatol; 2011 May; 131(5):1029-36. PubMed ID: 21191405 [TBL] [Abstract][Full Text] [Related]
19. Novel proline substitution mutations in keratin 16 in two cases of pachyonychia congenita type 1. Smith FJ; Del Monaco M; Steijlen PM; Munro CS; Morvay M; Coleman CM; Rietveld FJ; Uitto J; McLean WH Br J Dermatol; 1999 Dec; 141(6):1010-6. PubMed ID: 10606845 [TBL] [Abstract][Full Text] [Related]